Nov 27Anavex Life Sciences Reports Fiscal 2023 Year End Financial Results and Provides Business Update
Nov 24Anavex Life Sciences to Announce Fiscal 2023 Year End Financial Results on Monday, November 27, 2023
Oct 25Anavex Life Sciences Reports New Publication in Scientific Journal Demonstrating the Potential of
Sep 14Anavex’s Phase 2b/3 Trial of Blarcamesine (ANAVEX®2-73) in Patients with Alzheimer’s Disease
Sep 12Anavex Announces Appointment of Dr Marwan N Sabbagh, MD as Chairman of the Scientific Advisory Board